<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30396" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Amatoxin Mushroom Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Horowitz</surname>
            <given-names>B. Zane</given-names>
          </name>
          <aff>Oregon Health Science University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moss</surname>
            <given-names>Michael J.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>B. Zane Horowitz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Moss declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30396.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Amatoxin containing mushrooms are a rare but significant cause of acute fulminant liver failure. However, not all Amanita species have this toxin, and other mushroom species besides Amanita have the amatoxin. (Table) Ninety-five percent of deaths from mushroom ingestions worldwide are from amatoxin-containing mushrooms. This activity highlights the pathophysiology, presentation, and diagnosis of amatoxin mushroom toxicity and highlights the role of the interprofessional team in the management of these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of amatoxin mushroom poisoning.</p></list-item><list-item><p>Describe the clinical presentation of a patient having amatoxin mushroom poisoning.</p></list-item><list-item><p>Illustrate the treatment and management options available for amatoxin mushroom poisoning.</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care and outcomes in patients with amatoxin mushroom poisoning.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30396&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30396">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30396.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Amatoxin containing mushrooms are a rare but significant cause of acute fulminant liver failure. However, not all Amanita species have this toxin, and other mushroom species besides Amanita have the amatoxin. (Table) Ninety-five percent of deaths from mushroom ingestions worldwide are from amatoxin-containing mushrooms.<xref ref-type="bibr" rid="article-30396.r1">[1]</xref><xref ref-type="bibr" rid="article-30396.r2">[2]</xref><xref ref-type="bibr" rid="article-30396.r3">[3]</xref></p>
        <p>
<bold>Amatoxin containing mushroom species</bold>
</p>
        <p>
<bold>Amanita group:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Amanita phalloides</italic> (Death Cap)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Amanita virosa</italic>&#x000a0; (Destroying Angel)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Amanita verna</italic> (Fool&#x02019;s Mushroom)</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Amanita ocreata</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Amanita bisporigera</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Amanita suballiacea</italic>
</p>
          </list-item>
        </list>
        <p><bold>Lepiota group:</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>
<italic toggle="yes">Lepiota helveola</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Lepiota chlorophyllum</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Lepiota brunneolilacea</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Lepiota josserandi</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Lepiota fulvella</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Lepiota subincarnata</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Lepiota brunneoincarnata</italic>
</p>
          </list-item>
        </list>
        <p>
<bold>Miscellaneous:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Galerina autumnalis </italic>(Autumn skullcap)</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Galerina venenata</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Galerina sulcipes</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Conocybe filaris</italic>
</p>
          </list-item>
        </list>
        <p>Certain mushrooms frequently are mistaken for an edible mushroom when people are foraging. <italic toggle="yes">Amanita phalloides</italic> (Death cap), the species associated with the most fatalities, often are mistaken for the paddy straw mushroom.</p>
        <p>Both <italic toggle="yes">Agaricus volvacea</italic>, and <italic toggle="yes">Amanita bisporigera</italic> may be mistaken for edible, non-toxic <italic toggle="yes">Lepiota naucina</italic>.</p>
      </sec>
      <sec id="article-30396.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There are thousands of species of mushroom, but only about 50 to 100 of these are toxic to humans. The Amanita species are responsible for the majority of mushroom toxicity cases in humans. The Amanita mushrooms contain both amatoxins and phallotoxins. The amatoxins interfere with protein synthesis and cause liver failure.</p>
        <p>Other Amanita species such as <italic toggle="yes">Amanita smithiana</italic> contain a renal toxin, and <italic toggle="yes">Amanita muscaria</italic> and <italic toggle="yes">Amanita pantherina</italic> have isoxazole toxins, causing alterations in mental status but no liver or renal injury.</p>
      </sec>
      <sec id="article-30396.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Amanita poisoning occurs because most people are not able to tell which mushrooms species are safe for consumption when foraging. Also, certain people seek psychotropic mushrooms to get a &#x0201c;high&#x0201d; but mistakenly ingest amanita mushrooms. Amanita mushrooms have no distinct taste or odor but are large (5 cm to 15 cm) and often indistinguishable in color or appearance from edible species.<xref ref-type="bibr" rid="article-30396.r3">[3]</xref></p>
      </sec>
      <sec id="article-30396.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The amanitin toxin is heat stable, remaining toxic whether eaten raw or cooked. The mechanism of action of amatoxin is by inhibiting RNA polymerase, causing disruption of transcription of mRNA. As a result, hepatocytes cannot synthesize key protein coding genes, leading to the disintegration of nucleoli and pathologically centrilobular hepatic necrosis. This leads to the insidious onset of liver failure over 48 hours. Late onset (more than six hours after ingestion)&#x000a0;of vomiting and watery diarrhea occur due to the second component in some of these mushrooms which are phallotoxin. Lepiota species lack phallotoxins so may not have the onset of vomiting and diarrhea until after 12 hours post-ingestion, or may just present with symptoms of liver failure at 24 hours post ingestion.<xref ref-type="bibr" rid="article-30396.r4">[4]</xref></p>
      </sec>
      <sec id="article-30396.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Amatoxins are rapidly absorbed from the intestine and transported into the liver by OATP transporters. Once in the hepatocyte they start to&#x000a0;inhibit RNA polymerase. It takes about 24 hours before any signs or laboratory indicators of liver injury begin to&#x000a0;appear.</p>
      </sec>
      <sec id="article-30396.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The course of Amanita toxicity has three phases:</p>
        <list list-type="order">
          <list-item>
            <p>The first stage does not begin until six to 12 hours after ingestion; often foragers comment on how good the food made from Amanita species tastes, and there are no signs of a problem for at least 6 hours. After this silent phase, it is followed by the onset of nausea, abdominal cramps, profuse watery diarrhea, and signs of dehydration. A physical exam may reveal dry mucosal membranes and tachycardia, and given sufficient dehydration, hypotension.</p>
          </list-item>
          <list-item>
            <p>After the GI phase, the second stage appears where the patient appears to recover transiently, and GI symptoms resolve, but ongoing liver damage continues. This stage may last two to three days and is characterized by rising liver function transaminase, bilirubin, the development of coagulopathy, and eventually hepatic encephalopathy.</p>
          </list-item>
          <list-item>
            <p>In the third stage, both liver and renal function become compromised. Hepato-renal syndrome and hepatic encephalopathy may occur rapidly after laboratory signs of liver injury, and death can occur in three to seven days.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30396.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>All ingestions of suspected liver-toxic mushrooms should have a complete chemistry panel to include liver function tests and a baseline INR.<xref ref-type="bibr" rid="article-30396.r5">[5]</xref></p>
      </sec>
      <sec id="article-30396.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of Amatoxin mushroom toxicity is predominately supportive care. There is no specific antidote. The patient must have two large bore IVs and fluid loss, electrolyte deficiency, and glucose should be normalized. If the patient presents early (within two to four hours,) decontamination with oral activated charcoal may&#x000a0;be performed. Once the stomach is empty, nausea should&#x000a0;be treated&#x000a0;if needed.<xref ref-type="bibr" rid="article-30396.r1">[1]</xref><xref ref-type="bibr" rid="article-30396.r2">[2]</xref></p>
        <p>Several agents have been used and have anecdotal support in the literature:</p>
        <list list-type="order">
          <list-item>
            <p><bold>N-acetyl-cysteine:</bold> Used intravenously (IV) as per acetaminophen poisoning to treat potential liver injury, and provide glutathione.</p>
          </list-item>
          <list-item>
            <p><bold>Penicillin:</bold> High dose IV&#x000a0; (four million units every four&#x000a0;hours) is thought to compete with the liver uptake of the amatoxin.</p>
          </list-item>
          <list-item>
            <p><bold>Silymarin:</bold> Both the pharmaceutical form available in Europe as an intravenous formulation and the over the counter raw milk thistle extract used in North America have been used in a majority of cases in the literature. Its mechanism of action is felt to be an OAT-P transporter inhibitor that slows the entry of amatoxin into the liver. Doses are 1 gm orally four times daily, or its purified alkaloid silibinin intravenously&#x000a0; 5 mg/kg IV over one&#x000a0;hour, followed by 20 mg/kg/day as a constant infusion.</p>
          </list-item>
          <list-item>
            <p><bold>Activated charcoal:&#x000a0;</bold>May reduce absorption of amatoxins if given early after ingestion&#x000a0;and may&#x000a0;also prevent toxin readsorption&#x000a0;hours later as amatoxins undergo enterohepatic recirculation. A dose of 1 g/kg may be given every 2 to 4 hours.</p>
          </list-item>
          <list-item>
            <p><bold>Cyclosporine:</bold> Inhibitor of OAT-P transporter in&#x000a0;<italic toggle="yes">in vitro</italic> studies<xref ref-type="bibr" rid="article-30396.r6">[6]</xref>. Though cyclosporine is well studied for other indications, use for amatoxin mushroom toxicity is limited to case reports.</p>
          </list-item>
          <list-item>
            <p>A variety of other therapies, such as intravenous cimetidine or thioctic acid, have been tried but have only animal model support.</p>
          </list-item>
        </list>
        <p>In selected cases, once a severe liver injury occurs, despite aggressive fluid resuscitation and supportive care, a liver transplant may be the only life-saving option. Rapid progression to hepatic encephalopathy, hepatorenal syndrome, or coagulopathy are indications for liver transplantation. Consideration to transfer to a liver transplant setting and intensive care unit care should be done early in the course of&#x000a0;mushroom ingestions.</p>
        <p>When renal failure occurs, dialysis should be used, but its use even early after an ingestion does not remove Amatoxin from the blood.</p>
      </sec>
      <sec id="article-30396.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Confirmatory testing of amatoxin exposure is rarely available and relies on a strong supporting history. Thus, appropriate consideration should be given to other causes of acute hepatitis and liver failure such as acetaminophen overdose, infection, and autoimmune disorders.</p>
      </sec>
      <sec id="article-30396.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Renal and liver toxicity</p>
          </list-item>
          <list-item>
            <p>Encephalopathy</p>
          </list-item>
          <list-item>
            <p>Dehydration</p>
          </list-item>
          <list-item>
            <p>Pancreatitis</p>
          </list-item>
          <list-item>
            <p>Neuropathy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30396.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>A regional poison control center or medical toxicologist should be consulted in cases of amatoxin-containing mushroom exposure or suspected amatoxin hepatotoxicity. Additionally, poison control centers often collaborate with local mycologists who may be able to&#x000a0;aid in mushroom identification.</p>
      </sec>
      <sec id="article-30396.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The prognosis is dependent on the mushrooms ingested and the amount of&#x000a0;time it takes&#x000a0;to seek care.</p>
        <p>Death is rare if treatment is started immediately, and although fatalities continue to be reported, they occur in less than 5% of all cases in developed countries with early access to intensive care.</p>
        <p>The diagnosis of&#x000a0;amatoxin&#x000a0;poisoning can be made by the classic clinical course of rising liver transaminases within two to three days of foraging for mushrooms.</p>
        <p>Certain specialty laboratories can measure serum concentrations of amatoxin in blood, but the test is not reliable and often negative once symptoms begin.</p>
      </sec>
      <sec id="article-30396.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Mushroom poisoning is not very&#x000a0;common in the US but the toxicity can be very serious. Because the toxin can affect many organs in the body, an interprofessional team approach is necessary to make the diagnosis and manage the poisoning. The key factor that determines the outcome is the amount consumed. Data also indicate that there are some&#x000a0;individual variations in absorption; children tend to&#x000a0;absorb&#x000a0;higher doses of the toxin compared to adults and consequently have a much higher morbidity and mortality. The mortality rates following mushroom poisoning have dropped significantly in the US but liver failure appears to be a common adverse complication. There are reported cases where individuals&#x000a0;have required an immediate liver transplant as a lifesaving measure. The key to preventing mushroom poisoning is education of the public. In some cases, the mushrooms are safe but have been sprayed with toxic pesticides, hence thorough washing of the food is essential. There is no single test that can determine which mushroom is toxic; the best advice is do not eat wild mushrooms but instead buy them from a grocery store.<xref ref-type="bibr" rid="article-30396.r7">[7]</xref><xref ref-type="bibr" rid="article-30396.r8">[8]</xref><xref ref-type="bibr" rid="article-30396.r7">[7]</xref> (Level V)</p>
      </sec>
      <sec id="article-30396.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30396&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30396">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/poisons/amatoxin-mushroom-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30396">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30396/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30396">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30396.s16">
        <fig id="article-30396.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Amanita Phalloides Contributed by Zane Horowitz,M.D.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Amanita__Phalloides__1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30396.s17">
        <title>References</title>
        <ref id="article-30396.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diaz</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Amatoxin-Containing Mushroom Poisonings: Species, Toxidromes, Treatments, and Outcomes.</article-title>
            <source>Wilderness Environ Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-118</page-range>
            <pub-id pub-id-type="pmid">29325729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30396.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trakulsrichai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sriapha</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tongpoo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Udomsubpayakul</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Wongvisavakorn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srisuma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wananukul</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning.</article-title>
            <source>Int J Gen Med</source>
            <year>2017</year>
            <volume>10</volume>
            <fpage>395</fpage>
            <page-range>395-400</page-range>
            <pub-id pub-id-type="pmid">29138589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30396.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cervellin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Comelli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rastelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sanchis-Gomar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Luca</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and clinics of mushroom poisoning in Northern Italy: A 21-year retrospective analysis.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>697</fpage>
            <page-range>697-703</page-range>
            <pub-id pub-id-type="pmid">28905663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30396.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaneko</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tomomasa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kunimoto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fukusato</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Muraoka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gonmori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Morikawa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Amatoxin poisoning from ingestion of Japanese Galerina mushrooms.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>2001</year>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>413</fpage>
            <page-range>413-6</page-range>
            <pub-id pub-id-type="pmid">11527238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30396.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carneiro</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Concei&#x000e7;&#x000e3;o</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Paiva</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>de Pinho</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Baptista</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Lourdes Bastos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Co-ingestion of amatoxins and isoxazoles-containing mushrooms and successful treatment: A case report.</article-title>
            <source>Toxicon</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>103</volume>
            <fpage>55</fpage>
            <page-range>55-9</page-range>
            <pub-id pub-id-type="pmid">26091874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30396.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Letschert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Faulstich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Keppler</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Molecular characterization and inhibition of amanitin uptake into human hepatocytes.</article-title>
            <source>Toxicol Sci</source>
            <year>2006</year>
            <month>May</month>
            <volume>91</volume>
            <issue>1</issue>
            <fpage>140</fpage>
            <page-range>140-9</page-range>
            <pub-id pub-id-type="pmid">16495352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30396.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Chok</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Sin</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Liver transplantation: a life-saving procedure following amatoxin mushroom poisoning.</article-title>
            <source>Hong Kong Med J</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-6</page-range>
            <pub-id pub-id-type="pmid">28184019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30396.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schenk-Jaeger</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Rauber-L&#x000fc;thy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bodmer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kupferschmidt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kullak-Ublick</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Ceschi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mushroom poisoning: a study on circumstances of exposure and patterns of toxicity.</article-title>
            <source>Eur J Intern Med</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>e85</fpage>
            <page-range>e85-91</page-range>
            <pub-id pub-id-type="pmid">22560399</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
